- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/47 - Quinolines; Isoquinolines
Patent holdings for IPC class A61K 31/47
Total number of patents in this class: 5160
10-year publication summary
|
328
|
306
|
342
|
329
|
363
|
371
|
375
|
370
|
307
|
73
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 1581 |
118 |
| Exelixis, Inc. | 393 |
95 |
| Eisai R&D Management Co., Ltd. | 1304 |
94 |
| Janssen Pharmaceutica N.V. | 3839 |
65 |
| Aldeyra Therapeutics, Inc. | 100 |
54 |
| Bristol-myers Squibb Company | 5080 |
53 |
| Centre National de La Recherche Scientifique | 9632 |
45 |
| The Regents of the University of California | 18943 |
42 |
| Merck Sharp & Dohme LLC | 3689 |
38 |
| Boehringer Ingelheim International GmbH | 4629 |
36 |
| Merck Sharp & Dohme Corp. | 2247 |
35 |
| Taisho Pharmaceutical Co., Ltd. | 844 |
34 |
| F. Hoffmann-La Roche AG | 7958 |
32 |
| Abivax | 105 |
32 |
| Kowa Company, Ltd. | 1172 |
32 |
| Institut Curie | 531 |
31 |
| Novartis AG | 11238 |
30 |
| Universite de Montpellier | 920 |
27 |
| Amgen Inc. | 3779 |
26 |
| Coherus Biosciences, Inc. | 172 |
24 |
| Other owners | 4217 |